ARON 3D_Transparent

Supplementary studies

09

Impact of time-of-day administration of immunotherapy on survival in metastatic renal cellcarcinoma: the MOUSEION-09 meta-analysis

Alessandro Rizzo
et al. Clin Exp Metastasis
2024
0 3

Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study

Alessandro Rizzo
et al. Clin Exp Metastasis
2024
MOUSEION 07

Sex differences in adverse events among cancer patients receiving immune checkpointinhibitors: the MOUSEION-07 systematic review and meta-analysis

Elsa Vitale
Elsa Vitale et al. Sci Rep
2024
MOUSEION 06

The impact of ECOG performance status on efficacy of immunotherapy and immune-basedcombinations in cancer patients: the MOUSEION-06 study

Veronica Mollica
et al. Clin Exp Med
2023
MOUSEION 05

Hypertransaminasemia in cancer patients receiving immunotherapy and immune-basedcombinations: the MOUSEION-05 study

Alessandro Rizzo
et al. Cancer Immunol Immunother
2023
MOUSEION 04

Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: TheMOUSEION-04 Study

Alessandro Rizzo
et al. Cancers
2022

Do you want to join us ?

Join us today
ARON 3D_Transparent
Youtube Linkedin

Coordinated and designed by Atteggiamento Digitale .

Legal and Privacy.